Excellent products, solutions and systems for clinical cancer diagnostics

Our Product Worlds

Immunohistochemistry

  • Primary Antibodies
  • Detection Systems
  • Ancillary Reagents
  • Accessories

In Situ Hybridization

  • FISH & CISH Probes
  • Kits & Detection Systems
  • Filter Sets

Molecular Pathology

  • DNA Microarray Chips
  • Real-Time PCR Assays
  • NGS: Library Preparation Kits and Data Analyzer

Automation

  • Fully Automated Stainer
  • Semi Automated Stainer
  • Hybridizer

Control Material

  • Cell Control Arrays
  • Cell Control Slides

Our Companies

ZYTOMICS at a Glance

Founded in 2021, ZYTOMICS is a combination of three established and longstanding European cancer diagnostics companies: Zytomed Systems, ZytoVision and Diagomics. All original founders of these companies shared the same vision: enabling clinical pathologists to provide a precise and timely cancer diagnosis. Unified under ZYTOMICS, we proudly carry on the vision of our founders.

ZYTOMICS is a leading manufacturer and provider of products and solutions used in clinical cancer diagnostics. Our offering includes reagents, automation and analytics with a focus on immunohistochemistry, in situ hybridization and next generation sequencing diagnostics. We aim to be the partner of trust for clinical pathology laboratories by providing best-in-class product quality, regulatory compliance, clinical and scientific insights as well as supply reliability. We are certified in accordance with Regulation (EU) 2017/746 (IVDR) for a significant portion of our Class C devices portfolio.

ZYTOMICS has established a leading presence in major European markets and is consistently growing beyond European borders. Operations are located across sites in Northern Germany, Austria, Switzerland, and Southern France. Our international distribution network covers more than 90 countries.

Our Mission

Be the partner of trust for clinical pathology laboratories by providing best-in-class product quality, regulatory compliance, clinical and scientific insights as well as supply reliability.

Our Vision

Enable clinical pathologists to provide a precise and timely cancer diagnosis.

Our values


We believe in people empowerment to make the best decisions confidently, we embrace innovation to help our customers and staff achieving their goals in the most efficient and impactful manner, we foster collaborative diversity to come up with the most innovative ideas and solutions, and we promote continuous improvement to achieve lifelong professional growth as one team.

Key Facts

Employees: more than 170

Diversity: Overall 1/3 male; 2/3 female; Management team: 1/3 male; 2/3 female

Physical locations: Berlin, Bargteheide, Bremerhaven, Toulouse, Vienna, Zurich

In-house product brands: Zytomed Systems, ZytoDot, ZytoLight, ZytoMation, ZytoFast, FlexIsh, VisionArray, Nova Aura

(EU) 2017/746 (IVDR) certificate for class C devices: 150 ISH products

Direct sales channels: Germany, Austria, Switzerland, France, Belgium

Distributors worldwide: 65+

Download our Code of Conduct here

Management Team

Bastian Eirich

Group CEO

Claudia Zimmer

Group CFO

Monika Vosen

VP Global Sales

Gwénola Tanneau

Senior Director Sales for France/Belgium (former founder Diagomics)

Helle Sørensen

VP Business Development

Gaby Haas

VP Human Resources

Sandra Ehser

VP Operations

Julian Schmidt

VP QM, Sc. & Reg. Affairs

Dominik Anbergen

VP Marketing
ZytoMax GmbH
Anhaltinerstraße 16 | 14163 Berlin, Deutschland